CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

NCT04136171 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1438

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Interventions

DRUG: Eplontersen
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.

Collaborators

[object Object]